Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : MGTX save search
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
| Email alert
Add to watchlist
conference presentation
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: -8.87%
million pharmaceuticals milestone
Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors
Published: 2024-02-01 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: -1.13%
bioscience sanofi
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
Published: 2023-12-21 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 18.53%
H: 13.23%
C: 11.86%
collaboration agreement
MeiraGTx to Participate in Upcoming Investor Conferences
Published: 2023-11-21 (Crawled : 22:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 2.55%
H: 3.02%
C: -3.74%
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
Published: 2023-11-14 (Crawled : 13:30) - globenewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 3.59%
H: 1.63%
C: -1.22%
financial results
MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 10.27%
H: 32.6%
C: 9.07%
company
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
Published: 2023-10-24 (Crawled : 12:30) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 0.27%
H: 4.64%
C: -1.64%
congress presentation cell therapy
Janssen to Highlight Latest Advances in Retina Portfolio at the European Society of Retina Specialists (EURETINA) 2023 Annual Meeting
Published: 2023-10-03 (Crawled : 19:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.26%
H: 0.53%
C: 0.43%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.94%
retina meeting
NYC's Schwarzman Animal Medical Center Appoints Nicole Seligman as Co-Chair of Board of Trustees
Published: 2023-09-06 (Crawled : 12:00) - prnewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -2.97%
animal medical
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
Published: 2023-08-10 (Crawled : 12:20) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: -0.35%
H: 8.55%
C: 4.71%
financial results
MeiraGTx Announces Poster Presentation at the 2023 American Society of Gene and Cell Therapy (ASGCT) Spotlight on Immuno-Oncology
Published: 2023-08-01 (Crawled : 13:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: -0.79%
H: 2.08%
C: -2.88%
presentation cell therapy
MeiraGTx Announces its Wholly-Owned Gene Therapy Manufacturing Facility in Shannon, Ireland has Received Commercial MIA Authorization for QC Testing
Published: 2023-07-19 (Crawled : 12:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 0.46%
H: 15.38%
C: 7.54%
authorization commercial therapy
MeiraGTx Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
Published: 2023-06-27 (Crawled : 12:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 0.73%
H: 0.15%
C: -7.98%
positive treatment study
MeiraGTx to Present 12-month Data from All Cohorts of the Completed Phase 1 AQUAx Clinical Study and an Update on the Company’s Recently Initiated Phase 2 Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Tuesday, June 27, 2023
Published: 2023-06-22 (Crawled : 20:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: -2.33%
H: 7.45%
C: 4.92%
update treatment study initiated
MeiraGTx Announces the Presentation of Nine Posters at the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting
Published: 2023-05-16 (Crawled : 13:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 5.2%
H: 13.14%
C: 8.19%
presentation cell meeting therapy
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
Published: 2023-05-11 (Crawled : 12:20) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: -0.32%
H: 0.16%
C: -5.66%
financial results
MeiraGTx Announces $60 Million Private Placement of Ordinary Shares
Published: 2023-05-03 (Crawled : 13:00) - globenewswire.com
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 12.91%
H: 1.54%
C: -0.34%
Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors
Published: 2023-05-01 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 4.08%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
OVID | $3.22 0.31% 44K
|
Health Technology
|
| O: -1.4%
H: 3.4%
C: 2.83%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: -0.75%
H: 4.52%
C: 2.82%
collaboration therapeutics
Janssen to Highlight Innovation in Retinal Pipeline at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
Published: 2023-04-21 (Crawled : 14:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.53%
H: 0.32%
C: -1.06%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: -0.18%
H: 6.28%
C: 4.81%
association innovation pipeline research meeting
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.